[HTML][HTML] Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice
N Nikravesh, G Borchard, H Hofmann, E Philipp… - … , Biology and Medicine, 2020 - Elsevier
Iron deficiency is an important subclinical disease affecting over one billion people
worldwide. A growing body of clinical records supports the use of intravenous iron …
worldwide. A growing body of clinical records supports the use of intravenous iron …
Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose
The advantage of the new generation IV iron preparations ferric carboxymaltose (FCM),
ferumoxytol (FMX), and iron isomaltoside 1000 (IIM) is that they can be administered in …
ferumoxytol (FMX), and iron isomaltoside 1000 (IIM) is that they can be administered in …
[HTML][HTML] Iron-carbohydrate complexes treating iron anaemia: Understanding the nano-structure and interactions with proteins through orthogonal characterisation
Intravenous (IV) iron-carbohydrate complexes are widely used nanoparticles (NPs) to treat
iron deficiency anaemia, often associated with medical conditions such as chronic kidney …
iron deficiency anaemia, often associated with medical conditions such as chronic kidney …
Iron sucrose: assessing the similarity between the originator drug and its intended copies
T Di Francesco, E Philipp… - Annals of the New York …, 2017 - Wiley Online Library
Iron sucrose (IS) is a complex nanocolloidal intravenous suspension used in the treatment of
iron‐deficiency anemia. Follow‐on IS products (iron sucrose similars (ISSs)) have obtained …
iron‐deficiency anemia. Follow‐on IS products (iron sucrose similars (ISSs)) have obtained …
Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes
M Burgert, CB Marques, G Borchard, E Philipp… - JoVE (Journal of …, 2023 - jove.com
Intravenously administered iron-carbohydrate nanoparticle complexes are widely used to
treat iron deficiency. This class includes several structurally heterogeneous nanoparticle …
treat iron deficiency. This class includes several structurally heterogeneous nanoparticle …
Diluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability
E Philipp, M Braitsch, T Bichsel… - European Journal of …, 2016 - ejhp.bmj.com
Objectives This study was designed to assess the physicochemical stability of colloidal ferric
carboxymaltose solution (Ferinject) when diluted and stored in polypropylene (PP) bottles …
carboxymaltose solution (Ferinject) when diluted and stored in polypropylene (PP) bottles …
Iron polymaltose complexes: Could we spot physicochemical differences in medicines sharing the same active pharmaceutical ingredient?
T Di Francesco, L Delafontaine, E Philipp… - European Journal of …, 2020 - Elsevier
Oral iron therapy can efficaciously treat both iron deficiency and iron deficiency anemia. To
overcome the recurrent side effects of iron (II) salts, medicines containing iron (III) such as …
overcome the recurrent side effects of iron (II) salts, medicines containing iron (III) such as …
Energy Options
E Philipp - Science, 1999 - science.org
In the 30 July “Energy” issue, Richard Stone and Phil Szuromi (“Powering the next century,”
p. 677) do not take a global perspective when they write that others have “missed the mark …
p. 677) do not take a global perspective when they write that others have “missed the mark …
[CITATION][C] Pascal Münkner 9032 875
J Beck, D Schaupp, M Eckert, K Etzel, C Rossol, D Titt… - Lea, 2012
[CITATION][C] Radikalkationenreaktionen 9-substituierter Anthracene: Modellreaktionen zur Untersuchung der elektrophilen Nitrierung von Aromaten
E Philipp - 1991 - na